Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness of Commercial or Traditional Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Enhancing randomized controlled trials through smartwatch-guided participant matching for infectious disease outcomes.

Scientific reports·2026
Same author

Self-reported anal cancer screening experiences in MSM: recency, follow-up, and methodological insights.

Frontiers in oncology·2026
Same author

Health and Economic Impacts of Stable Housing Provision for Older Adults.

JAMA health forum·2026
Same author

Predictive Models to Identify Factors Associated with a High One-Time Sexual Partnership Rate Among U.S. Men Who Have Sex with Men.

AIDS and behavior·2026
Same author

Cost-Effectiveness of Continuous Glucose Monitoring With Remote Patient Monitoring in Pediatric Patients With Newly Diagnosed Type 1 Diabetes in the U.S.

Diabetes care·2026
Same journal

Optimal hospital capacity management during demand surges.

Health care management science·2026
Same journal

Towards optimal valve prescription for transcatheter aortic valve replacement (TAVR) surgery: a machine learning approach.

Health care management science·2026
Same journal

Efficient engagement: opportunities for mobile methadone maintenance in geographically underserved areas.

Health care management science·2026
Same journal

Ahead of the ambulance: Optimizing volunteer training.

Health care management science·2026
Same journal

A novel multi-criteria doctor ranking method considering patient risk attitudes and compensatory relationships.

Health care management science·2026
Same journal

Toward generalizable and interpretable machine learning models in healthcare: Insights from ICU outcome predictions.

Health care management science·2026
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Inferring model parameters in network-based disease simulation.

Eva A Enns1, Margaret L Brandeau

  • 1Department of Electrical Engineering, Stanford University, Stanford, CA 94035-6019, USA. evaenns@stanford.edu

Health Care Management Science
|March 5, 2011
PubMed
Summary
This summary is machine-generated.

This study introduces a network modeling framework to understand disease spread through contact networks. It helps evaluate interventions like HIV control programs by analyzing network structure and dynamics.

More Related Videos

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Related Experiment Videos

Last Updated: Jun 3, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Area of Science:

  • Epidemiology
  • Network Science
  • Public Health

Background:

  • Traditional infectious disease models often overlook contact network structures.
  • Understanding these networks is crucial for assessing disease control interventions.
  • Sexual and close contact networks significantly influence disease transmission dynamics.

Purpose of the Study:

  • To present a flexible network modeling framework for disease spread.
  • To introduce a methodology for inferring network parameters from available data.
  • To apply the framework to evaluate human immunodeficiency virus (HIV) control programs in sub-Saharan Africa.

Main Methods:

  • Developed a general network modeling framework for disease transmission.
  • Integrated a methodology for parameter inference from data.
  • Applied the model to simulate and assess HIV control strategies.

Main Results:

  • The framework effectively models disease spread through contact networks.
  • Parameter inference methodology proved viable for network dynamics.
  • The model provided insights into the potential impact of HIV interventions.

Conclusions:

  • Network modeling is essential for accurate infectious disease analysis.
  • The presented framework offers a versatile tool for public health research.
  • This approach can inform the design and evaluation of targeted disease control efforts.